Literature DB >> 23287866

OBFC2A/RARA: a novel fusion gene in variant acute promyelocytic leukemia.

Dahae Won1, So Youn Shin, Chan-Jeoung Park, Seongsoo Jang, Hyun-Sook Chi, Kyoo-Hyung Lee, Jin-Ok Lee, Eul-Ju Seo.   

Abstract

Acute promyelocytic leukemia is characterized by the rearrangement of the retinoic acid receptor α (RARA) gene and its fusion with other genes. We report a novel case of variant acute promyelocytic leukemia with the karyotype der (2)t(2;17)(q32;q21). Array comparative genomic hybridization revealed distinct chromosome breakpoints within the RARA and oligonucleotide/oligosaccharide-binding fold containing 2A (OBFC2A) genes. Sequence analysis of the OBFC2A/RARA transcript showed that exon 5 of OBFC2A was fused with exon 3 of RARA through the same breakpoint as in previously described fusions of RARA. The single-stranded DNA binding protein encoded by OBFC2A is critical for genomic stability. Retention of the OB fold domain of OBFC2A in the fusion protein suggests the possibility of homodimerization. The leukemic cells from the patient showed neutrophilic differentiation in the in vitro all-trans retinoic acid assay. Mutation or rearrangement of the OBFC2A gene has not been previously reported in congenital or acquired disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23287866     DOI: 10.1182/blood-2012-04-423129

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  The leukemic oncoprotein NPM1-RARA inhibits TP53 activity.

Authors:  Erin M Swaney; Anuja Chattopadhyay; Irina Abecassis; Elizabeth A Rush; Robert L Redner
Journal:  Leuk Lymphoma       Date:  2016-01-12

Review 2.  Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.

Authors:  Miguel A Sanz; Pierre Fenaux; Martin S Tallman; Elihu H Estey; Bob Löwenberg; Tomoki Naoe; Eva Lengfelder; Hartmut Döhner; Alan K Burnett; Sai-Juan Chen; Vikram Mathews; Harry Iland; Eduardo Rego; Hagop Kantarjian; Lionel Adès; Giuseppe Avvisati; Pau Montesinos; Uwe Platzbecker; Farhad Ravandi; Nigel H Russell; Francesco Lo-Coco
Journal:  Blood       Date:  2019-02-25       Impact factor: 22.113

3.  Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia.

Authors:  C Cameron Yin; Nitin Jain; Meenakshi Mehrotra; Jianhua Zhagn; Alexei Protopopov; Zhuang Zuo; Naveen Pemmaraju; Courtney DiNardo; Cheryl Hirsch-Ginsberg; Sa A Wang; L Jeffrey Medeiros; Lynda Chin; Keyur P Patel; Farhad Ravandi; Andrew Futreal; Carlos E Bueso-Ramos
Journal:  J Natl Compr Canc Netw       Date:  2015-01       Impact factor: 11.908

4.  Ssb1 and Ssb2 cooperate to regulate mouse hematopoietic stem and progenitor cells by resolving replicative stress.

Authors:  Wei Shi; Therese Vu; Didier Boucher; Anna Biernacka; Jules Nde; Raj K Pandita; Jasmin Straube; Glen M Boyle; Fares Al-Ejeh; Purba Nag; Jessie Jeffery; Janelle L Harris; Amanda L Bain; Marta Grzelak; Magdalena Skrzypczak; Abhishek Mitra; Norbert Dojer; Nicola Crosetto; Nicole Cloonan; Olivier J Becherel; John Finnie; Jeffrey R Skaar; Carl R Walkley; Tej K Pandita; Maga Rowicka; Krzysztof Ginalski; Steven W Lane; Kum Kum Khanna
Journal:  Blood       Date:  2017-03-07       Impact factor: 22.113

5.  IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid.

Authors:  Samir Mazharuddin; Anuja Chattopadhyay; Moshe Y Levy; Robert L Redner
Journal:  Leuk Lymphoma       Date:  2018-01-19

6.  NPM-RAR binding to TRADD selectively inhibits caspase activation, while allowing activation of NFκB and JNK.

Authors:  Anuja Chattopadhyay; Irina Abecassis; Robert L Redner
Journal:  Leuk Lymphoma       Date:  2015-10-05

Review 7.  Retinoid receptor signaling and autophagy in acute promyelocytic leukemia.

Authors:  Nina Orfali; Sharon L McKenna; Mary R Cahill; Lorraine J Gudas; Nigel P Mongan
Journal:  Exp Cell Res       Date:  2014-03-30       Impact factor: 3.905

Review 8.  Current views on the genetic landscape and management of variant acute promyelocytic leukemia.

Authors:  Xiang Zhang; Jiewen Sun; Wenjuan Yu; Jie Jin
Journal:  Biomark Res       Date:  2021-05-06

9.  A novel fusion protein TBLR1-RARα acts as an oncogene to induce murine promyelocytic leukemia: identification and treatment strategies.

Authors:  Shouyun Li; Xue Yang; Shuang Liu; Yirui Chen; Haiyan Xing; Kejing Tang; Zheng Tian; Yingxi Xu; Qing Rao; Min Wang; Jianxiang Wang
Journal:  Cell Death Dis       Date:  2021-06-11       Impact factor: 8.469

Review 10.  Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia.

Authors:  Guilherme Augusto Dos Santos; Lev Kats; Pier Paolo Pandolfi
Journal:  J Exp Med       Date:  2013-12-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.